1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Core Natural Resources and subsidiaries entered into a Receivables Financing Agreement dated July 28, 2025, with PNC Bank as administrative agent, supporting letters of credit and a borrowing capacity of $250 million, maturing July 27, 2028. The agreement replaces the existing receivables purchase arrangements dated October 5, 2016, and the company voluntarily repaid a prior 2017 receivables facility. The filing describes new fees and a guarantee by Core, which add to the company's direct financial obligations.
Borrowing capacity and letter of credit support of $250 million, maturing July 27, 2028
Loans accrue interest at term SOFR plus 10 basis points; letters of credit carry a 2.00% per annum participation fee
Prior CONSOL Funding receivables facility from November 30, 2017 was voluntarily repaid and its letters of credit transferred
Core guarantees the arrangement in favor of PNC Bank under a Fifth Amended and Restated Performance Guaranty
The filing names ASGN Incorporated, not Everforth Inc, so this summary covers ASGN. On July 31, 2025, ASGN signed a second amendment to its credit agreement and borrowed the full $100.0 million incremental Term A loan. The loan matures February 14, 2028, is secured by substantially all of the company's assets, and adds secured debt that must be repaid on a set amortization schedule.
Incremental Term A loan of $100.0 million, borrowed in full on July 31, 2025
Maturity date February 14, 2028; quarterly amortization of $625,000 for the first four fiscal quarters after the effective date, then $1,250,000 per quarter
Company must keep a consolidated secured leverage ratio of not greater than 3.75 to 1.00
Proceeds may fund organic investments, add availability under the $500 million revolving credit facility for acquisitions, and support share buybacks
CenterPoint Energy completed a private sale of $1.0 billion in 3.00% convertible senior notes due August 1, 2028, including a $100 million option exercised by the initial purchasers. Net proceeds were about $986.8 million, and the notes can convert into cash and common stock at an initial price of about $46.63 per share. The deal adds $1.0 billion of debt, with potential future share dilution of up to 26,809,600 shares, which shareholders should weigh against the added funding.
$1.0 billion principal of 3.00% convertible senior notes due August 1, 2028 sold in a private offering, including $100 million from the option exercise
Net proceeds of approximately $986.8 million after initial purchaser discounts and offering expenses
Initial conversion price of about $46.63 per share, a 25.0% premium to the July 28, 2025 NYSE closing price
Up to 26,809,600 shares of common stock may be issued on conversion; the company may pay cash up to principal
Healthcare Realty Trust and its operating partnership entered a new credit agreement dated July 25, 2025, replacing the existing facility with a $1.5 billion unsecured revolver and five unsecured term loan tranches totaling $1.115 billion. The revolver's maturity was extended from October 31, 2025 to July 25, 2029, which pushes out near-term refinancing needs for shareholders.
Revolver maturity extended from October 31, 2025 to July 25, 2029, with two six-month extension options
Five term loan tranches totaling $1.115 billion, with maturities ranging from October 31, 2025 to January 20, 2028
Current revolver margin is 0.85% per annum over the applicable benchmark, with a range of 0.725% to 1.40% based on credit ratings
Wells Fargo Bank, National Association serves as administrative agent
Sabra's operating partnership entered into a $500.0 million unsecured term loan on July 30, 2025, with an accordion feature that can raise total available borrowings to $1.0 billion. On July 31, 2025, the partnership redeemed all $500.0 million of its 5.125% Senior Notes due 2026, so the new loan refinances that debt.
Term loan of $500.0 million matures July 30, 2030; the accordion can increase total available borrowings to $1.0 billion, subject to terms.
Interest is SOFR-based or Base Rate plus a ratings-based margin of 0.800% to 1.600% for SOFR borrowings and 0.000% to 0.600% for Base Rate borrowings.
Interest rate swaps with $500.0 million notional fix the SOFR portion at a weighted average 3.44%, for an effective Term Loan rate of 4.64% through July 30, 2030.
The 2026 Notes were redeemed at 100.575% of principal plus accrued and unpaid interest.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.